I’ve been going down the ADAMAX rabbit hole recently because I’ve been looking into adding it to my research library — but before doing that, I wanted to make sure I was actually getting the correct product.
Here at DRL, I try to take the time to thoroughly research anything before adding it to the library. I want to understand what it is, how it's being tested, what makes it unique, and whether it actually brings meaningful value to researchers. I don't add products simply because they're popular, because everyone else has them, or because they have a good profit margin.
A good example is AOD. It's something I've looked at extensively, and it's not a product I've chosen to carry. Between the performance I've seen reported, the consistency issues, and the tendency for it to gel, I just don't believe it's a peptide that brings enough value to justify adding it to the lineup. I'd rather stock products I genuinely believe in than fill the catalog with products just because they're trending.
That's what led me down the ADAMAX rabbit hole in the first place.
From what I’ve been able to gather, ADAMAX is essentially a modified Semax structure with adamantane added to it. That adamantane modification is what separates ADAMAX from regular Semax.
This is where things get interesting.
A discussion came up in another forum that raised a pretty important point: some products being sold as ADAMAX may actually just be Semax without the adamantane modification.
One way people are identifying the difference is by looking at the monograph and analytical testing data. From the information shared, true ADAMAX should show the expected mass around 984.30 Daltons, and more importantly, it should also show a 1032 peak, which indicates the adamantane-modified version.
Without that 1032 peak, there’s a real possibility the product may be Semax — not ADAMAX.
What makes this even more confusing is that the CAS number won't help you on this particular peptide. Normally, many researchers use a CAS number as a quick way to verify identity, but in this case, that isn't enough to distinguish between Semax and ADAMAX. To know what you're actually looking at, you need to review the analytical data itself and understand what the peaks are telling you.
I’ve already seen one example where a vendor had it listed as ADAMAX, but the data looked more like Semax without the adamantane added. Is that automatically the vendor’s fault? Not necessarily. In some cases, the lab may not be testing it correctly, identifying it correctly, or labeling the distinction properly.
But either way, it matters.
This is exactly why deeper research is important in this space. Just because a label says ADAMAX doesn’t automatically mean the structure matches ADAMAX. You have to look at the actual data, the monograph, and whether the testing confirms the adamantane modification.
I also want to give a shout-out to VialTalk and their research forum. Resources like that are incredibly valuable because they allow researchers to go beyond the marketing and dig deeper into the actual science, testing data, and discussions surrounding these compounds. A lot of the information that helped point me in the right direction came from researchers sharing data, asking questions, and challenging assumptions.
Having access to a community that actively discusses analytical testing, monographs, mechanisms, and research applications is a huge benefit. It helps everyone become more informed researchers and make better decisions based on data rather than labels.
I've included a link below that does a great job explaining the differences between Semax and ADAMAX, how the adamantane modification changes the structure, and how the 1032 peak is used as part of identifying the modified compound within analytical testing.
The big takeaway:
ADAMAX = Semax + adamantane modification.
No 1032 marker = possibly not true ADAMAX.
CAS number alone won't tell you the difference. The analytical data will.
Do your homework. Ask for the data. Look at the peaks. Don't just trust the name on the vial.
